General Information of the Compound
Compound ID
CP0516142
Compound Name
US8802711, 70
    Show/Hide
Synonyms
PMID25666693-Compound-2
    Show/Hide
Structure
Formula
C22H21F2N3O
Molecular Weight
381.426
Canonical SMILES
Cc1cc2c(NC(=O)N[C@@H]3CC[C@@H](C3)c3ccccc3F)c(F)ccc2cn1
    Show/Hide
InChI
InChI=1S/C22H21F2N3O/c1-13-10-18-15(12-25-13)7-9-20(24)21(18)27-22(28)26-16-8-6-14(11-16)17-4-2-3-5-19(17)23/h2-5,7,9-10,12,14,16H,6,8,11H2,1H3,(H2,26,27,28)/t14-,16+/m0/s1
    Show/Hide
InChIKey
PJVXUKARZNCIRA-GOEBONIOSA-N
Physicochemical Property
logP
5.27922
Rotatable Bonds
3
Heavy Atom Count
28
Polar Areas
54.02
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 66549276
SID: 152141866
ChEMBL ID
CHEMBL3644125
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 5.6 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PMID25666693-Compound-2 )
Drug Name PMID25666693-Compound-2
Company ABBVIE INC
Indication
Osteoarthritis pain
Patented
Cancer related pain
Patented
Neuropathic pain
Patented
Inflammatory pain
Patented
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Antagonist